高级检索
    郑祖萍, 夏先如, 周发友, 唐晓磊. TWEAK诱导巨噬细胞源性外泌体miRNA抑制膀胱癌转移的研究[J]. 蚌埠医科大学学报, 2022, 47(2): 146-151. DOI: 10.13898/j.cnki.issn.1000-2200.2022.02.002
    引用本文: 郑祖萍, 夏先如, 周发友, 唐晓磊. TWEAK诱导巨噬细胞源性外泌体miRNA抑制膀胱癌转移的研究[J]. 蚌埠医科大学学报, 2022, 47(2): 146-151. DOI: 10.13898/j.cnki.issn.1000-2200.2022.02.002
    shu
    ZHENG Zu-ping, XIA Xian-ru, ZHOU Fa-you, TANG Xiao-lei. TWEAK-stimulated macrophages inhibit metastasis of bladder cancer via exosomal microRNAs[J]. Journal of Bengbu Medical University, 2022, 47(2): 146-151. DOI: 10.13898/j.cnki.issn.1000-2200.2022.02.002
    Citation: ZHENG Zu-ping, XIA Xian-ru, ZHOU Fa-you, TANG Xiao-lei. TWEAK-stimulated macrophages inhibit metastasis of bladder cancer via exosomal microRNAs[J]. Journal of Bengbu Medical University, 2022, 47(2): 146-151. DOI: 10.13898/j.cnki.issn.1000-2200.2022.02.002
    shu

    TWEAK诱导巨噬细胞源性外泌体miRNA抑制膀胱癌转移的研究

    TWEAK-stimulated macrophages inhibit metastasis of bladder cancer via exosomal microRNAs

      摘要
    • 摘要:
      目的研究肿瘤坏死因子样弱凋亡诱导因子（tumor necrosis factor-like weak inducer of apoptosis，TWEAK）诱导的肿瘤相关巨噬细胞（TMs）源性的外泌体对膀胱癌细胞的转移影响。
      方法使用TWEAK刺激THP-1诱导分化的TMs，检测其外泌体的特征。并使用miRNAs芯片检测TWEAK诱导的TMs中miRNAs的水平变化；随后通过激光共聚焦显微镜观察外泌体被膀胱癌ATCC 5637细胞系内化以及内化后ATCC 5637细胞中miRNAs的水平；同时检测外泌体处理对细胞的侵袭功能的影响以及活化的信号通路。
      结果TWEAK不仅增加巨噬细胞及其分泌的外泌体中miRNA-17-3p的水平，而且还导致受体ATCC 5637细胞中miRNA-17-3p的水平升高，这最终降低了表皮生长因子受体（epidermal growth factor recepto，EGFR）/苏氨酸激酶（threonine kinase，AKT）/细胞外调节蛋白激酶（extracellular regulated protein kinase，ERK1）1/2途径的活性。在TMs中预先转染antagomiR-17-3p显著性降低了巨噬细胞、巨噬细胞分泌的外泌体和受体ATCC 5637细胞中miR-17-3p的水平，并伴随着ATCC 5637的转移增强，表明TMs源性的外泌体miR-17-3p参与了ATCC 5637细胞转移的调节，且通过抑制EGFR/AKT/ERK1/2途径得以实现。
      结论TWEAK通过TMs将外泌体miRNAs转移到膀胱癌细胞中来抑制EGFR/AKT/ERK1/2途径，从而导致膀胱癌细胞的转移受到抑制。

       

      Abstract:
      ObjectiveTo explore the effect of exosomal-miRNAs from tumor necrosis factor-like weak inducer of apoptosis(TWEAK)-stimulated macrophages(TMs) on the metastasis of bladder cancer cells.
      MethodsThe characteristics of exosomes derived from TWEAK-stimulated TMs, THP-1 induced differentiation were observed.Through the miRNAs microarray analysis, the expressions of miRNAs in exosomes derived from TMs treated with or without TWEAK were detected.The internalization of bladder cancer ATCC5637 cells and miRNAs after the internalization were detected by the laser scanning confocal microscope.The effect of exosome from TWEAK-stimulated TMs on metastasis and signal-pathway in ATCC5637 cells were detected.
      ResultsTWEAK not only increased the levels of miR-17-3p in TMs and the secreted exosomes, but also resulted in an elevated levels of miR-17-3p in recipient ATCC 5637 cells, which eventually reduced the activity of the EGFR/AKT/ERK 1/2 pathway.Pre-transfection of antagomiR-17-3p in TMs substantially decreased the levels of miR-17-3p in macrophages, its secreted exosomes and the recipient ATCC 5637 cells with a concomitant enhancement of ATCC 5637metastasis, suggesting an involvement of exosomal miR-17-3p from TMs in modulating the metastasis of ATCC 5637cells.And miR-17-3p inhibited the metastasis of bladder cancer cells via the EGFR/AKT/ERK 1/2 pathway.
      ConclusionsTWEAK transfers exosomal miRNAs to bladder cancer cells via TMs to inhibit the EGFR/AKT/ERK 1/2 pathway, resulting in the inhibition of metastasis in bladder cancer cells.

       

      • HTML全文
      • 参考文献(18)
      • 相关文章
      • 施引文献
    • 资源附件(0)

    /

    返回文章
    返回